{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:13:15Z","timestamp":1770819195167,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ejmech.2012.07.017","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T23:33:41Z","timestamp":1343086421000},"page":"188-194","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ligand-based design, in silico ADME-Tox filtering, synthesis and biological evaluation to discover new soluble 1,4-DHP-based CFTR activators"],"prefix":"10.1016","volume":"55","author":[{"given":"Sonja","family":"Visentin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ermondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Medana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2012.07.017_bib1","series-title":"Cystic Fibrosis in the 21st Century","author":"Bush","year":"2006"},{"key":"10.1016\/j.ejmech.2012.07.017_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.ejmech.2012.07.017_bib4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective \u0394 F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2012.07.017_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10822-010-9390-0","article-title":"Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening","volume":"24","author":"Kalid","year":"2010","journal-title":"Comput. Aid. Mol. Des."},{"key":"10.1016\/j.ejmech.2012.07.017_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/mol.107.034702","article-title":"Structure-activity relationship of 1,4-Dihydropyridines as potentiators of the cystic fibrosis transmembrane conductance regulator chloride channel","volume":"72","author":"Pedemonte","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"23","key":"10.1016\/j.ejmech.2012.07.017_bib7","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1016\/j.bmc.2009.10.028","article-title":"Synthesis of 4-thiophen-2\u2032-yl-1, 4-dihydropyridines as potentiators of the CFTR chloride channel","volume":"17","author":"Cateni","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2012.07.017_bib8","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/S0968-0896(03)00435-8","article-title":"Benzoflavone activators of the cystic fibrosis transmembrane conductance regulator: towards a pharmacophore model for the nucleotide-binding domain","volume":"11","author":"Springsteel","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"37","key":"10.1016\/j.ejmech.2012.07.017_bib9","doi-asserted-by":"crossref","first-page":"35079","DOI":"10.1074\/jbc.M303098200","article-title":"Nanomolar affinity small molecule correctors of defective \u0394F508-CFTR chloride channel gating","volume":"278","author":"Yang","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib10","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1021\/jm200199r","article-title":"Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines","volume":"54","author":"Budriesi","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2012.07.017_bib11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1124\/mol.105.015149","article-title":"Antihypertensive 1,4-Dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations","volume":"68","author":"Pedemonte","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2012.07.017_bib12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.drudis.2009.08.004","article-title":"Dihydropyridines: evaluation of their current and future pharmacological applications","volume":"14","author":"Edraki","year":"2009","journal-title":"DDT"},{"key":"10.1016\/j.ejmech.2012.07.017_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A\u00a0computational procedure for determining energetically favorable binding sites on biological important macromolecules","volume":"28","author":"Goodford","year":"1985","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/jm00053a018","article-title":"Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds","volume":"36","author":"Wade","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib15","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/jm000941m","article-title":"GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors","volume":"43","author":"Pastor","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2012.07.017_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/ci800037t","article-title":"Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in molecular interaction fields","volume":"48","author":"Pastor","year":"2008","journal-title":"J.\u00a0Chem. Inf. Mod."},{"key":"10.1016\/j.ejmech.2012.07.017_bib17","series-title":"Molecular Interaction Fields - Applications in Drug Discovery and ADME Prediction","author":"Cruciani","year":"2005"},{"issue":"3","key":"10.1016\/j.ejmech.2012.07.017_bib18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ejmech.2010.12.024","article-title":"An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) inhibitors","volume":"46","author":"Ermondi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib19","series-title":"Guidance Document on the Validation of (Quantitative) Structure-activity Relationship ((Q)SAR) Models","author":"Organization for Economic Co-operation and Development","year":"2007"},{"key":"10.1016\/j.ejmech.2012.07.017_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-1280(99)00360-7","article-title":"Molecular fields in quantitative structure \u2013 permeation relationships: the Volsurf+ approach","volume":"503","author":"Cruciani","year":"2000","journal-title":"J.\u00a0Mol. Struct. (THEOCHEM)"},{"key":"10.1016\/j.ejmech.2012.07.017_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1248\/cpb.41.1049","article-title":"Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties and the 3- and 5- positions","volume":"41","author":"Ogawa","year":"1993","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2012.07.017_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1248\/cpb.41.108","article-title":"Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position","volume":"41","author":"Ogawa","year":"1993","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2012.07.017_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(25)12561-3","article-title":"Kinetics of binding of membrane-active drugs to receptor sites","volume":"27","author":"Rhodes","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2012.07.017_bib24","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1021\/jm800151n","article-title":"Discovery of novel and cardioselective diltiazem- like calcium channel blockers via virtual screening","volume":"51","author":"Carosati","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2012.07.017_bib25","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.ejmech.2008.11.009","article-title":"GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers","volume":"44","author":"Ermondi","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2012.07.017_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/17425250903055070","article-title":"hERG-related drug toxicity and models for predicting hERG liability and QT prolongation","volume":"5","author":"Raschi","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejmech.2012.07.017_bib27","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1021\/jm0704651","article-title":"Influence of conformation on GRIND-based three-dimensional quantitative structure-activity relationship ( 3D-QSAR )","volume":"50","author":"Caron","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.07.017_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1023\/A:1018974409622","article-title":"NO donor and biological properties of different benzofuroxans","volume":"16","author":"Medana","year":"1999","journal-title":"Pharm. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412004436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412004436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T08:35:09Z","timestamp":1743842109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523412004436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":28,"alternative-id":["S0223523412004436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2012.07.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}